Skip to main content

Eli Lilly’s psoriasis drug gets DCGI nod, company forays in dermatology segment in India

Eli Lilly’s psoriasis drug gets DCGI nod, company forays in dermatology segment in India The Indianapolis headquartered company said Copellor will be a prescription medicine to be used only on the advice of a dermatologist or rheumatologist and under medical supervision.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/eli-lilly’s-psoriasis-drug-gets-dcgi-nod-company-foraysdermatology-segmentindia_16926201.html
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch
Post a Comment
Read more

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc
Post a Comment
Read more